S&P 500   3,341.53 (-0.94%)
DOW   28,974.30 (-0.84%)
QQQ   231.57 (-1.37%)
AAPL   316.03 (-1.33%)
FB   211.26 (-1.55%)
MSFT   180.74 (-2.00%)
GOOGL   1,500.91 (-1.06%)
AMZN   2,117.05 (-1.67%)
CGC   21.95 (-1.61%)
NVDA   298.02 (-3.46%)
BABA   214.05 (-1.83%)
MU   57.05 (-3.31%)
AMD   55.22 (-3.58%)
T   38.49 (-0.31%)
F   7.94 (-1.12%)
PRI   132.49 (-2.87%)
BAC   34.32 (-1.52%)
DIS   139.13 (-0.88%)
GILD   69.08 (+3.10%)
S&P 500   3,341.53 (-0.94%)
DOW   28,974.30 (-0.84%)
QQQ   231.57 (-1.37%)
AAPL   316.03 (-1.33%)
FB   211.26 (-1.55%)
MSFT   180.74 (-2.00%)
GOOGL   1,500.91 (-1.06%)
AMZN   2,117.05 (-1.67%)
CGC   21.95 (-1.61%)
NVDA   298.02 (-3.46%)
BABA   214.05 (-1.83%)
MU   57.05 (-3.31%)
AMD   55.22 (-3.58%)
T   38.49 (-0.31%)
F   7.94 (-1.12%)
PRI   132.49 (-2.87%)
BAC   34.32 (-1.52%)
DIS   139.13 (-0.88%)
GILD   69.08 (+3.10%)
S&P 500   3,341.53 (-0.94%)
DOW   28,974.30 (-0.84%)
QQQ   231.57 (-1.37%)
AAPL   316.03 (-1.33%)
FB   211.26 (-1.55%)
MSFT   180.74 (-2.00%)
GOOGL   1,500.91 (-1.06%)
AMZN   2,117.05 (-1.67%)
CGC   21.95 (-1.61%)
NVDA   298.02 (-3.46%)
BABA   214.05 (-1.83%)
MU   57.05 (-3.31%)
AMD   55.22 (-3.58%)
T   38.49 (-0.31%)
F   7.94 (-1.12%)
PRI   132.49 (-2.87%)
BAC   34.32 (-1.52%)
DIS   139.13 (-0.88%)
GILD   69.08 (+3.10%)
S&P 500   3,341.53 (-0.94%)
DOW   28,974.30 (-0.84%)
QQQ   231.57 (-1.37%)
AAPL   316.03 (-1.33%)
FB   211.26 (-1.55%)
MSFT   180.74 (-2.00%)
GOOGL   1,500.91 (-1.06%)
AMZN   2,117.05 (-1.67%)
CGC   21.95 (-1.61%)
NVDA   298.02 (-3.46%)
BABA   214.05 (-1.83%)
MU   57.05 (-3.31%)
AMD   55.22 (-3.58%)
T   38.49 (-0.31%)
F   7.94 (-1.12%)
PRI   132.49 (-2.87%)
BAC   34.32 (-1.52%)
DIS   139.13 (-0.88%)
GILD   69.08 (+3.10%)
Log in

Daxor News Headlines (NYSEAMERICAN:DXR)

$9.30
-0.15 (-1.59 %)
(As of 02/21/2020 11:23 AM ET)
Today's Range
$9.30
Now: $9.30
$9.45
50-Day Range N/A
52-Week Range
$7.13
Now: $9.30
$19.95
Volume1,209 shs
Average Volume1,639 shs
Market Capitalization$34.86 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Headlines

Daxor (NYSEAMERICAN DXR) News Headlines

Source:
DateHeadline
New Research Further Demonstrates Clinical Superiority of Daxor Corporation’s Blood Volume Analyzer (BVA-100®) in Critical CareNew Research Further Demonstrates Clinical Superiority of Daxor Corporation’s Blood Volume Analyzer (BVA-100®) in Critical Care
finance.yahoo.com - February 20 at 9:11 AM
Daxor Co. (NYSEAMERICAN:DXR) Short Interest UpdateDaxor Co. (NYSEAMERICAN:DXR) Short Interest Update
www.americanbankingnews.com - February 14 at 3:22 AM
Daxor Corporation to Exhibit at the Society for Critical Care Medicine 49th CongressDaxor Corporation to Exhibit at the Society for Critical Care Medicine 49th Congress
finance.yahoo.com - February 12 at 12:38 PM
Heres What We Think About Daxor Corporations (NYSEMKT:DXR) CEO PayHere's What We Think About Daxor Corporation's (NYSEMKT:DXR) CEO Pay
finance.yahoo.com - December 31 at 12:56 PM
Here's What We Think About Daxor Corporation's (NYSEMKT:DXR) CEO PayHere's What We Think About Daxor Corporation's (NYSEMKT:DXR) CEO Pay
finance.yahoo.com - December 31 at 12:56 PM
Novel Study from Yale University Utilizes Daxor’s Blood Volume Analyzer (BVA-100®) to Uncover Important Mechanism for Drug EmpagliflozinNovel Study from Yale University Utilizes Daxor’s Blood Volume Analyzer (BVA-100®) to Uncover Important Mechanism for Drug Empagliflozin
finance.yahoo.com - November 21 at 8:58 AM
Daxor Corporation to Exhibit at American Heart Association’s Scientific Sessions 2019Daxor Corporation to Exhibit at American Heart Association’s Scientific Sessions 2019
finance.yahoo.com - November 12 at 8:05 AM
Read This Before Judging Daxor Corporation's (NYSEMKT:DXR) ROERead This Before Judging Daxor Corporation's (NYSEMKT:DXR) ROE
finance.yahoo.com - October 29 at 8:05 AM
Daxor to Present at the Inaugural MicroCap Rodeo Investor Conference on October 15, 2019 at 1:30 PM Central TimeDaxor to Present at the Inaugural MicroCap Rodeo Investor Conference on October 15, 2019 at 1:30 PM Central Time
finance.yahoo.com - October 10 at 11:29 AM
Newly Published Study Demonstrates Clinical Utility of Daxor’s Blood Volume (BVA-100) Diagnostic in the Assessment of HypertensionNewly Published Study Demonstrates Clinical Utility of Daxor’s Blood Volume (BVA-100) Diagnostic in the Assessment of Hypertension
finance.yahoo.com - September 24 at 9:19 AM
New Data Presented on Blood Volume at Annual Heart Failure Society Meeting Amid Call to Broadly Adopt Daxor’s Diagnostic TechnologyNew Data Presented on Blood Volume at Annual Heart Failure Society Meeting Amid Call to Broadly Adopt Daxor’s Diagnostic Technology
finance.yahoo.com - September 18 at 8:51 AM
Daxor Corporation to Exhibit at the 23rd Annual Scientific Meeting of the Heart Failure Society of AmericaDaxor Corporation to Exhibit at the 23rd Annual Scientific Meeting of the Heart Failure Society of America
finance.yahoo.com - September 11 at 8:55 AM
Daxor Corporation Announces a 38 Percent Rise in BVA-100 Cardiology Kit Sales and Net Gain of $498,111 for Six Months in Filing of Form N-CSR for June 30, 2019Daxor Corporation Announces a 38 Percent Rise in BVA-100 Cardiology Kit Sales and Net Gain of $498,111 for Six Months in Filing of Form N-CSR for June 30, 2019
finance.yahoo.com - September 4 at 11:31 AM
How Do Daxor Corporation’s (NYSEMKT:DXR) Returns Compare To Its Industry?How Do Daxor Corporation’s (NYSEMKT:DXR) Returns Compare To Its Industry?
finance.yahoo.com - August 30 at 7:07 PM
Daxor Corporation Announces the Acquisition of the BVA-100® Blood Volume Analyzer by a Leading Academic Health Center in the Pacific NorthwestDaxor Corporation Announces the Acquisition of the BVA-100® Blood Volume Analyzer by a Leading Academic Health Center in the Pacific Northwest
finance.yahoo.com - August 6 at 8:44 AM
Daxor Corporation Announces New Research Initiative with Leading Hospital in the Southeast and the BVA-100® Blood Volume Diagnostic TestDaxor Corporation Announces New Research Initiative with Leading Hospital in the Southeast and the BVA-100® Blood Volume Diagnostic Test
finance.yahoo.com - June 18 at 5:31 PM
Daxor Corporation to Present at the LD Micro 9th Annual Invitational on June 4th, 2019Daxor Corporation to Present at the LD Micro 9th Annual Invitational on June 4th, 2019
finance.yahoo.com - May 31 at 9:26 AM
Daxor Corporation Announces New Partnership with Leading Hospital in North Carolina to Integrate the BVA-100® Blood Volume Analyzer Diagnostic Test as Part of Standard Clinical PracticeDaxor Corporation Announces New Partnership with Leading Hospital in North Carolina to Integrate the BVA-100® Blood Volume Analyzer Diagnostic Test as Part of Standard Clinical Practice
finance.yahoo.com - May 30 at 9:25 AM
Our Take On Daxor Corporations (NYSEMKT:DXR) CEO SalaryOur Take On Daxor Corporation's (NYSEMKT:DXR) CEO Salary
finance.yahoo.com - May 27 at 5:51 PM
Our Take On Daxor Corporation's (NYSEMKT:DXR) CEO SalaryOur Take On Daxor Corporation's (NYSEMKT:DXR) CEO Salary
finance.yahoo.com - May 27 at 5:51 PM
Daxor Corp.Daxor Corp.
www.barrons.com - May 6 at 6:40 PM
Daxor Corporation to Exhibit at the Society of Hospital Medicine (SHM) Annual Conference 2019Daxor Corporation to Exhibit at the Society of Hospital Medicine (SHM) Annual Conference 2019
www.globenewswire.com - March 22 at 6:22 PM
Daxor Corporation Addresses and Corrects Erroneous Seeking Alpha Healthcare News Editor Article of March 20, 2019Daxor Corporation Addresses and Corrects Erroneous Seeking Alpha Healthcare News Editor Article of March 20, 2019
finance.yahoo.com - March 21 at 8:56 AM
Daxor down 11% after corporate presentationDaxor down 11% after corporate presentation
seekingalpha.com - March 20 at 7:01 PM
Daxor Corporation to Present at the 31st Annual Roth Conference on March 19, 2019Daxor Corporation to Present at the 31st Annual Roth Conference on March 19, 2019
finance.yahoo.com - March 15 at 9:43 AM
New Research Further Demonstrates Clinical Utility and Improved Ease of Use with Daxor Corporation’New Research Further Demonstrates Clinical Utility and Improved Ease of Use with Daxor Corporation’
www.nasdaq.com - February 22 at 10:15 AM
Daxors BVA-100 demonstrates ease of use in critically ill patientsDaxor's BVA-100 demonstrates ease of use in critically ill patients
seekingalpha.com - February 22 at 10:15 AM
New Research Further Demonstrates Clinical Utility and Improved Ease of Use with Daxor Corporation’s Blood Volume Analyzer (BVA-100®) in Critical CareNew Research Further Demonstrates Clinical Utility and Improved Ease of Use with Daxor Corporation’s Blood Volume Analyzer (BVA-100®) in Critical Care
finance.yahoo.com - February 22 at 10:15 AM
Daxor Corporation to Exhibit at the Society for Critical Care Medicine 48th CongressDaxor Corporation to Exhibit at the Society for Critical Care Medicine 48th Congress
finance.yahoo.com - February 13 at 9:33 AM
Daxor Corporation Appoints Guido Manzo, Vice President of SalesDaxor Corporation Appoints Guido Manzo, Vice President of Sales
finance.yahoo.com - January 23 at 9:13 AM
Daxor Corporation Announces Acquisition of BVA-100® Blood Volume Analyzer to Aspirus Wausau Hospital in WisconsinDaxor Corporation Announces Acquisition of BVA-100® Blood Volume Analyzer to Aspirus Wausau Hospital in Wisconsin
finance.yahoo.com - January 10 at 9:45 AM
This page was last updated on 2/21/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel